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Growth inhibitory response and ultrastructural
modification of oral-associated candidal reference strains
(ATCC) by Piper betle L. extract
Mohd-Al-Faisal Nordin1, Wan Himratul-Aznita Wan Harun1, Fathilah Abdul Razak1 and Md Yusoff Musa2
Candida species have been associated with the emergence of strains resistant to selected antifungal agents. Plant products have been
used traditionally as alternative medicine to ease mucosal fungal infections. This study aimed to investigate the effects of Piper betle
extract on the growth profile and the ultrastructure of commonly isolated oral candidal cells. The major component of P. betle was
identified using liquid chromatography-mass spectrophotometry (LC-MS/MS). Seven ATCC control strains of Candida species were
cultured in yeast peptone dextrose broth under four different growth environments: (i) in the absence of P. betle extract; and in the
presence of P. betle extract at respective concentrations of (ii) 1mg?mL21; (iii) 3mg?mL21; and (iv) 6mg?mL21. The growth inhibitory
responses of the candidal cells were determinedbased on changes in the specific growth rates (m). Scanning electronmicroscopy (SEM)
was used to observe any ultrastructural alterations in the candida colonies. LC-MS/MS was performed to validate the presence of
bioactive compounds in the extract. Following treatment, it was observed that the m-values of the treated cells were significantly
different than those of the untreated cells (P,0.05), indicating the fungistatic properties of the P. betle extract. The candidal
population was also reduced from an average of 13.443106 to 1.783106 viable cell counts (CFU)?mL21. SEM examination exhibited
physical damage and considerable morphological alterations of the treated cells. The compound profile from LC-MS/MS indicated the
presence of hydroxybenzoic acid, chavibetol and hydroxychavicol in P. betle extract. The effects of P. betle on candida cells could
potentiate its antifungal activity.
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INTRODUCTION
Candida species represent a component of the normal flora in the oral
cavity. However, under certain favorable conditions, these species can
become opportunistic and cause infections in the oral cavity of immu-
nocompromised hosts. This process occurs when there is a change in
the ecological balance within the oral cavity that favors Candida over
other microorganisms. Candida albicans has often been reported as
the predominant species associated with superficial and systemic fun-
gal infections.1 Of late, however, the prevalence of C. albicans has
surpassed by the emergence of non-Candida albicans Candida spe-
cies,2–4 and increased prescription of antifungal agents5 has been sug-
gested to be a contributing factor. The increased number of
compromised patients with common endocrine disorders such as
diabetes mellitus,6 with malnutrition and with smoking habits,7 has
been identified to be primarily responsible for the development of
candidal infections. The wearing of dentures has also resulted in pro-
found alterations in the normal oral flora, providing an opportunity
for candida to colonize the underlying mucosa.8
The normal carriage rate of Candida in the oral cavity varies from
2% to 71%,9 but can reach 100% in medically compromised patients
and those on broad-spectrum antibacterial agents.10 Seven species of
Candida have been identified in the oral cavity, and among these,
C. albicans has been reported as the most prevalent pathogen in both
mucosal and systemic fungal infections,11 while C. glabrata is the
second or third most isolated pathogen in patients with oral candido-
sis.12 Candida possesses a multitude of virulence factors, and a key
attribute to its virulence is its adaptability for growth. Thus, an under-
standing of the physiological growth process of the cells could better
explain and support the sustainability of cells growing under unfavor-
able growth conditions.
Natural products as traditional remedies are in great demand, as
they are perceived to have minimal side effect on humans.13 Malaysia
is well known for its diverse possession of flora and fauna. Piper betle L.
is a tropical creeper plant belonging to the pepper family. Decoctions
prepared from the leaves are used to relieve coughing and asthma and
to help in the treatment of halitosis, joint pain and itchiness.14 It is also
popular as an antiseptic that is commonly applied on wounds and
lesions for its healing effects.15 The extract of P. betle leaves has been
reported to possess anti-oxidative,16 anti-inflammatory, antibacterial
and antifungal activities.17–19 The minimal inhibitory concentration
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and minimal fungicidal concentration of P. betle extract against can-
didal species were reported to be within the range of 12.5–
25.0 mg?mL21.19 This study aimed to investigate the effects of P. betle
extract on the growth profiles and ultrastructures of seven ATCC
control strains of commonly isolated Candida species that have been
associated with the oral cavity. The data obtained were analyzed to
validate the antifungal effects of P. betle extract on these strains. Major
components of P. betle were identified using liquid chromatography-
mass spectrophotometry (LC-MS/MS). Findings from the study could
provide better understanding of the antifungal effects of the extract on
the physiological growth processes of oral candidal strains and the
morphology of colonies.
MATERIALS AND METHODS
Plant collection and extract preparation
Fresh leaves of P. betle were collected from a local farm in Selangor,
Malaysia. The specimens were scientifically identified by a botanist
from the Institute of Biological Science, Faculty of Science,
University of Malaya. The voucher specimen was deposited at the
Herbarium of Rimba Ilmu, University of Malaya, under reference
number KLU 046620. Crude aqueous extract of the specimen was
prepared according to Himratul-Aznita et al.19 The specimen was
washed and oven-dried at 60–65 6C for 2 days. The dried specimen
was homogenized in distilled water at a ratio of specimen to water of
1 : 10. The homogenate was heated at a high temperature and concen-
trated to one-third of the original volume. The concentrate was fil-
tered through filter paper (Whatman No. 1) before it was further
heated to a final volume of 100 mL. The decoction was then concen-
trated overnight by freeze–drying (FDU-1200; EYELA, Tokyo, Japan).
The powder obtained was kept in sterile Falcon polypropylene conical
bottom tubes and was stored at 4 6C. Prior to use, a stock solution of
the extract was prepared in sterile distilled water at a concentration of
200 mg?mL21. Following centrifugation (Jouan A14; Jouan, Saint
Herblain, France) for 10 min at 8 000g, the stock was then diluted to
the concentrations required for the experiment. The extract was steri-
lized by filtration using a 0.2 mm nylon syringe filter (Millipore,
Billerica, MA, USA).
Microbial strains
Seven strains of oral Candida, which included Candida albicans ATCC
14053,Candida dubliniensisATCCMYA-2975, Candida glabrataATCC
90030, Candida krusei ATCC 14243, Candida lusitaniae ATCC 64125,
Candida parapsilosis ATCC 22019 and Candida tropicalis ATCC 13803,
were purchased from the American Type Culture Collection (ATCC,
Manassas, VA, USA) for use in the study. Yeast peptone dextrose (YPD)
broth (BD Difco, Sparks, MD, USA) was used to revive the cultures.
Preparation of standard candidal suspension
Stocks of the Candida strains were revived in 5 mL of YPD broth and
were allowed to propagate overnight at 37 6C in a horizontal incubator
shaker. The cells were then harvested by centrifugation at 8 000g (10 6C)
for 5 min. The supernatant was discarded, while the pellet was washed
twice with sterile saline (8.5 g?L21). The pellet was resuspended in 40 mL
of YPDbroth, and the concentration of the suspensionwas adjusted to an
optical density of 0.144 at 550 nm. At this optical density, the cell popu-
lation was equivalent 13106 cells per mL or to #0.5 McFarland standard.
Growth profiles of Candida species
Five milliliters of candidal suspension (3106 cells per mL) were dis-
pensed into three sterile conical flasks, each containing 40 mL of YPD
broth. Sterile distilled water (5 mL) was added to yield a total volume
of 50 mL in each flask. The flasks were incubated at 37 6C
(C. parapsilosis at 35 6C) for 18 h in a shaking water bath to agitate
the suspension continuously. Spectrophotometric assay,20 which is
based on continuous monitoring of changes in the optical density of
cell growth, was employed. Cell growth was measured periodically at
one-hour intervals over a period of 18 h at an optical absorbance of
550 nm. The growth of different candidal species could be distinguished
by measuring the changes of specific growth rates (m), using the equa-
tion previously described:21–22
m~
ln Nt=N0ð Þ
t2{t1
where Nt represented the number of cells at log phase, N0 represented
the number of cells at zero time, t2 was the time taken to reach plateau
and t1 zero was the time when the cells entered the log phase. The m-
values were distinguished from the exponential phase, during which the
cells appearing per unit time were proportional to the present popu-
lation. The growth of seven candidal species was also determined based
on the viable cell counts (CFUs), estimated at 2, 6, 10, 14 and 16 h
intervals. The cell suspension was first diluted by serial dilution in a
nontoxic diluent (e.g., phosphate-buffered saline, pH 7.2–7.4) before
plating. To serve as a positive control, chlorhexidine (1.2 g?L21)-con-
taining mouth rinse was used in place of the extract.
Growth inhibitory activity of P. betle extract
P. betle extract was prepared into stocks of 10, 30 and 60 mg?mL21.
Five milliliters of each stock concentration was dispensed into sterile
conical flasks containing 40mL of YPD broth, followed by 5 mL of the
respective candidal suspension (13106 cells per mL) to yield final con-
centrations of 1, 3 and 6mg?mL21 of the extract. In a similarmanner, the
culture flasks were placed in a shaking water bath at 37 6C (C. parapsilosis
was incubated at 35 6C), and the growth of cells in the presence of the
extract wasmeasured periodically at 1-h intervals over a period of 18 h.
Changes in specific growth rate (m) were calculated, and the findings
were compared with those of the standard. The inhibitory effect of the
extract was also determined, based on viable cell counts.
Scanning electron microscope examination
Fresh candidal suspension was cultured on YPD agar, and the colonies
were allowed to grow for 24 h. Using a sterile blade, the agar was cut to
approximately 1 cm31 cm and was transferred into a sterile vial to be
treated with the 6 mg?mL21 extract for 4 h. Prior to scanning electron
microscope (SEM) processing, the samples were prefixed with a 4%
glutaraldehyde solution overnight at 4 6C. The samples were then
washed with 0.1 mol?L21 sodium cacodylate buffer (pH 7.4), followed
by fixation in 2% osmium tetroxide in the buffer solution overnight.
The next day, the samples were gently washed in distilled water twice for
15 min and were dehydrated in an ascending series of ethanol concen-
trations (10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90% and 95%)
for 15 min each. The samples were then dehydrated twice in 100%
ethanol for 15 min and subsequently were dehydrated in an ethanol–
acetone mixture at ratios of 3 : 1, 1 : 1 and 1 : 3 for 15 min each. Then,
the samples were treated three times with pure acetone for 15 min. The
samples were processed for critical point drying (Balzers CPD 030; Bal-
Tec AG, Balzers, Liechtenstein) for 2 h in liquid CO2 under 95 bar
pressure. Finally, the samples were gold-coated under low pressure
with an ion sputter coater (JOEL JFC1100; JEOL, Tokyo, Japan). Any
physical changes in the morphology of the candidal cells were observed
with a scanning electron microscope.
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Liquid chromatography-mass spectrophotometry analysis
Liquid chromatography-mass spectrophotometry (LC-MS/MS) analysis
was performed with a Perkin-Elmer FX 15 UHPLC (Flexar autosampler,
Flexar binary pump, Flexar column oven, Flexar degasser; PerkinElmer,
Waltham, MA, USA) coupled to an AB SCIEX 3200QTrap MS/MS
system, in the electrospray ionization negative mode. Ten microliters
of the sample were injected onto a Phenomenex Aqua column C18
(50 mm32.0 mm35 mm particle size). The mobile phases, consisting
of solvent A (water with 0.1% formic acid and 5 mmol?L21 ammonium
formate) and solvent B (acetonitrile with 0.1% formic acid and
5 mmol?L21 ammonium formate), were used in gradient mode with
the following conditions (time/concentration) for B: 0.0 min/5%; 8.0
min/90%; 10.0 min/90%; 10.1 min/5%; 15.0 min/5%; and with a flow
rate between 0.25 and 0.4 mL?min21. Rapid screening was performed at
15 min of run time, and the scan range of MS–MS wasm/z 50–260. The
extract was diluted five times with water and was filtered with a 0.2 mm
nylon filter prior to analysis. The spectrum of the unknown component
was compared with the spectra of the known components stored in the
MS/MS library. The name and molecular weight of the components of
the extract were ascertained.
Statistical analysis
All of the data obtained were computed and are expressed as the
mean6standard deviation (s.d.) from three independent experiments
performed in triplicate (n59). Statistical analysis was performed using
SPSS (Statistical Package for the Social Sciences) software (version
17.0; SPSS, Chicago, IL, USA). An independent t-test was used to
compare the significant differences between controls (untreated)
and P. betle-treated samples for each individual candidal species.
One-way analysis of variance was applied to compare the specific
growth rates (m) of the seven Candida species upon exposure to P.
betle extract. A P value ,0.05 was considered statistically significant.
RESULTS
Normal growth curves of Candida strains
The normal growth curves of all seven candidal strains were cultured
under normal, untreated growth conditions. The curves were all sigmoi-
dal, with clear exhibition of the lag, log and stationary phases. Varying
durations of the lag and log phases were observed among the different
species. In general, approximately 5–7 h was required by the cells to adapt
to the normal growth environment before they were ready to proliferate
and enter the log phase. C. tropicalis showed the highest growth rates
(0.31960.002) h21 indicating high proliferation. The others were in the
range of (0.14160.001)–(0.26560.005) h21. Based on the enumeration
of CFUs, it was shown that the population of candidal species increased
gradually from 1.003105 to 1.6131010 CFU?mL21 over 18 h of incuba-
tion (Figure 1).
Growth curves of Candida strains following treatment with P. betle
extract
The patterns of the growth curves of all seven candidal strains were
altered and showed deviations from the normal sigmoidal pattern
following treatment with P. betle extract. Extension of the lag phases
and suppression of cell growth were indicated by the reduction in m-
values (Table 1). The growth suppression effect of the extract was
found to be concentration-dependent.
At 1mg?mL21, them-values ofCandida species weremostly reduced
by a range of 15%–42%. The reduction ofC. parapsilosis, however, was
not significant (P50.537). Exposing the candidal cells to 3 mg?mL21
of the extract drastically reduced the m-values of all of the Candida
species to almost half of the untreated cells. C. dubliniensis was con-
sidered the most susceptible to the extract (97.61%), followed by
C. lusitaniae (88.68%) and C. albicans (88.21%). The m-value reduc-
tions of the four others were comparatively lower, in the range of 48%–
71%. The m-values of all of the species were more than 90% reduced at
6 mg?mL21 of P. betle (P,0.05). Except for C. krusei (P50.513),
significant reductions in the specific growth rates of all of the strains
were observed at 6 mg?mL21 (P,0.05). Deviations in the m-values
resulted in extension of the lag and log phases. Based on CFU enu-
meration, the populations of all of the candidal species also showed
reductions of an average of (13.443106)–(1.783106) CFU?mL21
(Figure 1).
Morphology of Candida strains following treatment with P. betle
extract
Treated samples of Candida were observed by SEM to investigate any
physical changes in the appearance of the cells. Figure 2 shows the
SEM images of the untreated and P. betle-treated candidal species. The
Table 1 Changes in the specific growth rates (m) of the seven candidal species that was grown in the absence (untreated) and presence of Piper
betle extract
Candida species Specific growth rates (m) Untreated
Piper betle extract treated
1 mg?mL21 3 mg?mL21 6 mg?mL21
C. albicans ATCC 14053 m/h21 0.26360.011 0.15260.008 0.03160.005 0.00560.005
Reduction in m/% — 42.21 88.21 98.10
C. dubliniensis ATCC MYA-2975 m/h21 0.25160.010 0.18360.014 0.00660.004 0.00460.003
Reduction in m/% — 27.09 97.61 98.41
C. glabrata ATCC 90030 m/h21 0.26360.004 0.17460.008 0.09960.012 0.01160.006
Reduction in m/% — 33.84 62.36 95.82
C. krusei ATCC 14243 m/h21 0.25160.006 0.15160.006 0.07760.007 0.02760.005
Reduction in m/% — 39.84 69.32 89.24
C. lusitaniae ATCC 64125 m/h21 0.26560.005 0.18060.009 0.03060.004 0.01260.003
Reduction in m/% — 32.08 88.68 95.47
C. parapsilosis ATCC 22019 m/h21 0.14160.001 0.13960.002 0.07460.004 0.01060.003
Reduction in m/% — 1.42 47.52 92.91
C. tropicalis ATCC 13803 m/h21 0.31960.002 0.27160.004 0.10960.004 0.00860.007
Reduction in m/% — 15.05 65.83 97.49
ATCC, American Type Culture Collection.
Values were obtained from spectrophotometric assay and expressed as mean6standard deviation of three independent experiments performed in triplicate (n59).
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non-treated cells were entirely intact, and they had attained optimum
cell sizes within the range of (3.13 mm32.33 mm)–(6.65 mm31.95 mm)
(Table 2). These non-treated cells were smooth-surfaced and rounded,
and some were elongated in their well-developed structures. It was
observed that the cells were in the active dividing state, as the inter-
connecting processes and buds were present.
Some physical changes and morphological alterations in the can-
didal cells were observed following treatment with P. betle extract. It
was found that the cells were slightly smaller. Based on the inde-
pendent t-test, the mean lengths of C. albicans, C. glabrata and
C. lusitaniae were significantly different (P,0.05) between the
untreated and P. betle-treated cells. The widths of all of the candidal
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Figure 1 The population of candidal species under treatment with P. betle extract at 1 , 3 and 6 mg?mL21. Chlorhexidine was used as a reference. The data are
expressed as the mean6standard deviation of three independent experiments performed in triplicate (n559).
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cells, however, were not significant, except for that of C. albicans
(P50.011) (Table 2). Despite the minimal changes in the sizes of
the cells, alterations of their morphology might be an indication of
the inhibitory effects of the extract, which in one way or another
affected the growth profile of Candida cells. Some candidal cells
shrank and became flaccid due to the decomposition of the cell
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Figure 2 Composite micrographs illustrating the morphological changes of seven Candida species treated with P. betle extract, compared to untreated candidal
cells. (a) C. albicans; (b) C. dubliniensis; (c) C. glabrata; (d) C. krusei; (e) C. lusitaniae; (f) C. parapsilosis; (g) C. tropicalis. 1, Control, untreated; 2, treated with
P. betle extract. Magnification: 35000. , Dense deposits; , buds and dividing state; , decomposition and shrunk; , punctates.
Table 2 Deviations in the sizes of candidal cells following treatment of Piper betle extract
Candida species
Normal P. betle extract treated
Length/mm Width/mm Length/mm Width/mm
C. albicans ATCC 14053 3.9360.30 3.0760.15 3.2060.51a 2.7360.19a
C. dubliniensis ATCC MYA-2975 4.1160.48 2.4060.15 3.5760.47 2.4360.13
C. glabrata ATCC 90030 3.1360.39 2.3360.39 2.4360.23a 1.8760.45
C. krusei ATCC 14243 6.6560.52 1.9560.16 6.0060.71 1.8560.48
C. lusitaniae ATCC 64125 3.8060.44 2.5660.25 3.1660.24a 2.4060.21
C. parapsilosis ATCC 22019 4.5660.34 2.3660.28 4.0460.63 2.3260.25
C. tropicalis ATCC 13803 3.8060.51 2.8060.18 3.7760.59 2.9060.33
ATCC, American Type Culture Collection.
aP,0.05 comparing to the untreated (normal) candidal cell sizes.
Values are expressed as mean6standard deviation of nine determinations (n59).
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wall. Among the treated candidal cells, deposition of heavy, mesh-
like extracellular matrix was observed, which resulted in a fluffy
appearance around the cells (Figure 2).
Identification of the main constituents of Piper betle
The chromatogram of LC-MS/MS and the associated analytical data
showed that themain constituents of P. betle leaf extract corresponded
to hydroxychavicol, chavibetol and hydroxybenzoic acid. It was clearly
demonstrated that hydroxychavicol was a predominant component in
crude P. betle extract (Table 3).
DISCUSSION
The selection of the ATCC reference strainsC. albicans,C. dubliniensis,
C. glabrata, C. krusei, C. lusitaniae, C. parapsilosis and C. tropicalis was
based on various reports of the prevalence of Candida species in the
oral cavity.2,10,23–24 Although the reference strains were isolated ori-
ginally from blood, similar strains have also been reported as present
in the oral cavity.25–27
It was found that P. betle extract exhibited varying degrees of growth
inhibitory effects on species of Candida without displaying cytotoxic
effects on normal cell lines.28 C. dubliniensis appeared to be the most
susceptible strain to P. betle, compared to the others. Disruption of the
normal physiological growth of candidal cells was indicated by the
deviation of the growth curves from the normal pattern. Upon the
addition of P. betle extract to the growth environment, the log phase of
Candida species was reduced and shifted to the right. The presence of a
higher concentration of P. betle extract affected the specific growth
rates of seven candidal species. Therefore, this extract demonstrated
fungistatic activity towards seven candidal species and successfully
suppressed the cells, causing them to become dormant and unable
to proliferate actively.
Those cells grown in the presence of P. betle extract could have
experienced environmental stress, which might have influenced their
ability to use nutrients efficiently, thereby slowing their growth. In
addition, their metabolisms might have been deactivated while wai-
ting for the environment to revert to the normal condition. This effect
was previously observed for Candida species when growth curves
based on capacitance were obtained.29 It was observed that the fun-
gistatic effect of the extract was concentration-dependent. The higher
the concentration was, the more the critical turbidity was delayed.
resulting in a longer lag phase. Fathilah et al.18 reported that the early
settlers of dental plaque also experienced bacteriostatic effects when
treated with P. betle extract, indicating that P. betle extract has a sig-
nificant antimicrobial activity against a broad spectrum of oral micro-
organisms.
SEM images demonstrated that there were alterations in the mor-
phology of Candida cells following treatment with P. betle extract.
Dense deposits were observed when a matrix was formed on the sur-
face of the cells, as indicated by the arrows ( ) in Figure 2 (a2, b2, c2
and f2). Some species were able to retain their structures and their
buds while they were still in the actively dividing state, as indicated by
the open arrows ( ) in Figure 2 (a1, b1–b2, c1, d1, e1–e2, f1–f2
and g1). The destructive effects of the extract on the cells might have
been minimal, but there was a possibility of certain cell wall constitu-
ents that were less firmly bound to the rigid glucan-chain network
being lost during the extract treatment. As a result, the ions’ and
nutrients’ uptake mechanisms, which normally occur on the cell sur-
faces, could have been restricted. Figure 2 (c2, d2 and g2) clearly
demonstrates that the cells endured decomposition of the cell wall,
some which shrank (circled; ) and showed apparent loss of cell
density. This finding explains the reduction in sizes of the treated cells
relative to the untreated cells. In addition, the punctate appearance
(arrow head; ), which was observed to be randomly positioned on
the surface of untreated C. krusei30 and C. lusitaniae, disappeared
following treatment with the extract, which illustrated the direct
effects of P. betle extract on the candidal cell walls. Similar findings
were also reported by Nakamura et al.31 with regard to the effects on
the morphology and ultrastructure of yeasts.
The extract of P. betle leaf has been reported to possess various
chemical constituents,32–34 that could be isolated from the solvent
extract. In the present study, hydroxychavicol, chavibetol and hydro-
xybenzoic acid were among the bioactive constituents found present
in the aqueous extract of P. betle. They were similar to the types that
were previously identified as present in the other solvent extracts.
Hydroxychavicol, which is a phenol, was the major compound in P.
betle extract. In the presence of hydroxychavicol, the extract might
have the tendency to act as an antioxidant and a chemopreventive
agent, and it might possess anticarcinogenic activities.35 There have
been several previous studies reporting the antibacterial and antifun-
gal activities of hydroxychavicol.36 Chavibetol, an isomer of eugenol,
was regarded as one of the most active components against Gram-
positive and Gram-negative bacteria.37 Hydroxybenzoic acid is a
phenolic derivative of benzoic acid, and it has also been reported to
possess antifungal effects on the mycelia growth of Eutypa lata.38 The
antimicrobial action has been shown to be determined by more than
one compound,39 which are responsible not only for the antimicrobial
activity but also for the synergistic effect. The mechanism of action of
these components is expected to be similar to those of other terpenes
and phenolic compounds, which allow for the adherence of Candida
to host tissue surfaces before it can penetrate to target sites. The dis-
tortion of wall components and the disruption of the cytoplasmic
membrane cause coagulation of the cell contents, thus leading to a
loss of structural integrity and of the ability of themembrane to act as a
permeability barrier.40 These changes can be attributed to the fun-
gistatic activity and affect the physiological functions of Candida. In
addition, the extensive loss of the cell contents and the efflux of critical
molecules and ions due to high concentrations of extractmight initiate
an autolytic process that results in cell death.
In conclusion, this study showed that betel leaf extract possessed
potent fungistatic activity on Candida species. The suppression of cell
growth and the alterations in morphology diminished the population
of Candida and reduced the likelihood of its invading and colonizing
the oral tissues. The presence of bioactive components in the crude
aqueous extract of P. betle also suggests that betel leaves have the
potential to be used as an antifungal agent in oral health care products
in the future.
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